Lysis of tumor cells by antibody and complement. VII. Complement-dependent 86Rb release--a nonlethal event?
The guinea pig hepatoma (line-1) treated with anti-Forssman antibody (TA) and GPC sequentially released 86Rb, 14C from 14C aminoidobutyric acid and failed to exclude trypan blue. Incubation of TA with fluid phase GPC for 1 min caused maximal 86Rb release; however, if the GPC was removed at this time, the cells were not subsequently killed. Using a number of naturally occurring human sera deficient in a complement component we have shown 86Rb release requires the binding of the complement components 1 through 8, but there was no absolute requirement for C9. Irreversible damage to the cell as measured by 14C AIB release or uptake of trypan blue required the complete sequence of complete sequence of complement components. These observations indicate that 86Rb release is not a relible indicator cytotoxicity.
D000818:Animals; D000906:Antibodies; D001665:Binding Sites; D006528:Carcinoma, Hepatocellular / Q000276:immunology*; D003185:Complement C8 / Q000378:metabolism; D003186:Complement C9 / Q000378:metabolism; D003165:Complement System Proteins / Q000378:metabolism*; D003601:Cytotoxicity Tests, Immunologic; D006168:Guinea Pigs; D006801:Humans; D008113:Liver Neoplasms / Q000276:immunology*; D012413:Rubidium
D000906:Antibodies; D003185:Complement C8; D003186:Complement C9; D003165:Complement System Proteins; D012413:Rubidium